Filter posts

Video: Emerging Company CEOs Praise JOBS Act

Passed in 2012, the Jumpstart Our Business Startups (JOBS) Act makes the pathway to capital …

San Francisco Business Times: Two JOBS Acts are better than one

Today, the San Francisco Business Times published an op-ed by OncoMed President and CEO Paul Hastings lauding …

More than a Quarter of 2013 US-Based Biotech IPOs Call California Home

And of those 39 US-based biotech companies, five of them are from San Diego, highlighting …

BIO White Paper Highlights Key Industry Legislation and its Impact on the Industry

Innovative biotech companies at all stages of the development process are working toward next generation …

What’s Behind the Biotech IPO Boom?

Everyone knows that it’s been a knock-out year for the biotech sector in the public …

Lots of Buzz at the BIO Investor Forum

Thirty-eight biotech IPO’s this year. The NASDAQ Biotechnology Index is up 50 percent YTD.  Are …

JOBS Act Deconstructed: Confidential Filing

More than 40 biotech companies have gone public using provisions made available to emerging growth …

JOBS Act Deconstructed: Testing-the-Waters

More than 40 biotech companies have gone public using provisions made available to emerging growth …

Crowdfunding in Health Care and Biotechnology

Smaller private companies are constantly in search of capital, but many find it difficult to …

The New Road to IPO in the Age of the JOBS Act

Not surprisingly, sessions discussing the topic of IPOs at this year’s BIO Investor Forum, tend …